Mandatum Life Insurance CO LTD Gilead Sciences, Inc. Transaction History

Mandatum Life Insurance CO LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$64.88 - $73.64 $4.14 Million - $4.7 Million	-63,793 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$60.0 - $68.46 $8,340 - $9,515	-139 Reduced 0.22%	63,793 $4.12 Million
Q4 2020 Feb 10, 2021	SELL	$56.65 - $64.55 $10,763 - $12,264	-190 Reduced 0.3%	63,932 $3.73 Million
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $13,744 - $15,960	190 Added 0.3%	64,122 $4.93 Million
Q1 2020 May 08, 2020	SELL	$62.63 - $80.22 $4,446 - $5,695	-71 Reduced 0.11%	63,932 $4.78 Million
Q3 2019 Nov 08, 2019	BUY	$62.51 - $69.0 $1.35 Million - $1.49 Million	21,537 Added 50.72%	64,003 $4.06 Million
Q3 2017 Nov 09, 2017	BUY	$72.11 - $85.47 $3.06 Million - $3.63 Million	42,466	42,466 $3.44 Million

1,879

1.02B

12M

8.96M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Mandatum Life Insurance CO LTD, based on Form 13F filings with the SEC.

Stay updated on Mandatum Life Insurance CO LTD with notifications on news.